Panion & BF Biotech Inc (1760.TW) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · Taiwan · ISIN TW0001760007
Panion & BF Biotech Inc financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 2.03 bn TWD | 2.06 bn TWD |
| Gross profit | 1.07 bn TWD | 1.12 bn TWD |
| Operating income | 205.67 m TWD | 307.85 m TWD |
| EBIT | 240.89 m TWD | 307.85 m TWD |
| Net income | 124.52 m TWD | 190.17 m TWD |
| Diluted EPS – continuing operations | 1.45 TWD | 2.22 TWD |
Full history since 2009, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Panion & BF Biotech Inc
Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, provides western medicines, cosmetics, testing reagents, food and chemical products in Taiwan, the United States, China, Hong Kong, Macau, and internationally. The company offers products in the areas of antibody, respiratory, gastrointestinal, COVID-19 IVD, antigen, anti-aging, active pharmaceutical ingredients, disease treatment, prevention, and veterinary products. It also offers nephrology, dermatology, pain management, hospital and household sanitization, and personal hygiene services. Panion & Bf Biotech Inc. was founded in 1976 and is headquartered in Taipei, Taiwan.
More stocks
- Cullman Bancorp, Inc. /MD/ (CULL)
- Mi Chang Oil (003650.KS)
- Zapata Quantum, Inc. (ZPTA)
- Sea Sonic Electronics Co Ltd (6203.TWO)
- Banca Profilo SpA (PRO.MI)
- BMT Co. Ltd (086670.KQ)
- Boab Metals Ltd (BML.AX)
- Schwager (SCHWAGER.SN)
- Northcliff Resources Ltd (NCF.TO)
- Exel Composites Oyj (EXEL.HE)
- Legacy Ventures International Inc (LGYV)
- Organogenesis Holdings Inc. (ORGO)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.